ACADIA Pharmaceuticals Inc. - Laporan Laba Rugi (TTM)

ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
Laporan Laba Rugi (TTM)

Laporan Laba Rugi ACADIA Pharmaceuticals Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 419 442 458 463 474 484 493 512 512 517 520 551 632 726 814 891 929 958 996 1,019
Change (%) 5.41 3.73 1.12 2.38 2.06 1.84 3.92 -0.18 1.12 0.58 5.90 14.70 14.96 12.03 9.43 4.35 3.07 4.02 2.27
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 335 287 271 263 204 259 329 345 363 372 311 299 387 393 405 433 347 385 401 405
Change (%) -14.39 -5.56 -2.82 -22.65 26.95 27.13 4.92 5.28 2.38 -16.41 -3.89 29.50 1.68 3.01 6.97 -19.88 10.92 4.16 1.05
% of Revenue 79.97 64.94 59.13 56.83 42.93 53.40 66.66 67.30 70.99 71.87 59.73 54.21 61.21 54.14 49.78 48.66 37.36 40.21 40.26 39.78
Gross Operating Profit 84 155 187 200 271 226 164 168 148 145 209 252 245 333 409 457 582 573 595 614
Change (%) 84.47 20.94 6.80 35.33 -16.67 -27.14 1.93 -11.41 -1.96 43.98 20.41 -2.83 35.93 22.68 11.86 27.30 -1.60 3.92 3.09
% of Revenue 20.03 35.06 40.87 43.17 57.07 46.60 33.34 32.70 29.01 28.13 40.27 45.79 38.79 45.86 50.22 51.34 62.64 59.79 59.74 60.22
SG&A 360 389 398 411 411 396 381 374 371 369 374 380 399 407 413 434 470 488 507 523
Change (%) 8.03 2.49 3.12 0.02 -3.61 -3.78 -1.81 -0.95 -0.41 1.23 1.62 5.21 1.77 1.66 5.10 8.15 3.96 3.76 3.24
% of Revenue 85.85 87.98 86.93 88.66 86.61 81.80 77.28 73.02 72.45 71.36 71.82 68.93 63.22 55.97 50.79 48.78 50.56 50.99 50.87 51.36
R&D
Change (%)
% of Revenue
OpEx 695 676 669 674 615 655 710 719 734 741 684 678 786 800 818 868 817 874 908 929
Change (%) -2.79 -0.93 0.72 -8.84 6.52 8.43 1.31 2.04 0.97 -7.62 -0.88 15.90 1.72 2.32 6.03 -5.84 6.92 3.94 2.28
% of Revenue 165.82 152.92 146.06 145.48 129.54 135.20 143.95 140.32 143.44 143.23 131.56 123.14 124.43 110.10 100.56 97.44 87.92 91.20 91.13 91.14
Operating Income -276 -234 -211 -211 -140 -170 -217 -207 -222 -224 -164 -127 -154 -73 -5 23 112 84 88 90
Change (%) -15.24 -9.73 -0.14 -33.50 21.62 27.13 -4.64 7.53 0.63 -26.58 -22.35 21.11 -52.47 -93.75 -597.60 391.94 -24.91 4.84 2.19
% of Revenue -65.82 -52.92 -46.06 -45.48 -29.54 -35.20 -43.95 -40.32 -43.44 -43.23 -31.56 -23.14 -24.43 -10.10 -0.56 2.56 12.08 8.80 8.87 8.86
Interest Expense
Change (%)
% of Revenue
Net Income -268 -282 -260 -262 -192 -168 -214 -205 -217 -216 -146 -111 -149 -61 -2 31 129 226 229 222
Change (%) 5.12 -7.66 0.67 -26.82 -12.36 27.76 -4.60 6.22 -0.63 -32.43 -24.07 34.29 -58.82 -97.21 -1,887.43 320.44 76.22 1.07 -2.94
% of Revenue -63.92 -63.74 -56.74 -56.49 -40.37 -34.67 -43.50 -39.93 -42.49 -41.76 -28.05 -20.12 -23.55 -8.44 -0.21 3.43 13.83 23.64 22.97 21.80

Source: Capital IQ

Other Listings
DE:DR6 € 21.73
GB:0A4W
US:ACAD US$ 25.26
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista